Search
Platycodon grandiflorus root
go.drugbank.com/drugs/DB14347InvestigationalPlatycodon grandiflorus root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Citrus junos fruit
go.drugbank.com/drugs/DB14348InvestigationalCitrus junos fruit is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Citrus X Junos Fruit, Citrus X Wilsonii FruitPlatycodon grandiflorus leaf
go.drugbank.com/drugs/DB14356InvestigationalPlatycodon grandiflorus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Ilex paraguariensis leaf
go.drugbank.com/drugs/DB14366InvestigationalIlex paraguariensis leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Camphor leaf oil
go.drugbank.com/drugs/DB14378InvestigationalCamphor leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Camphor Oil Formosan Ho-sho Leaves, Camphor Oil, Formosan Ho-sho, Leavesbeta-Sitosterol
go.drugbank.com/drugs/DB14038InvestigationalActive fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity.
Synonyms: (3β)-Stigmast-5-en-3-ol, (24R)-ethylcholest-5-en-3β-olMixtures: Mi-Omega NFPropionate ion
go.drugbank.com/drugs/DB19384InvestigationalPropionate ion is under investigation in clinical trial NCT00846326 (Preventing Tolerance to Oxymetazoline in Allergic Rhinitis).
Synonyms: Propanoate ion, Propionate ionPilaralisib
go.drugbank.com/drugs/DB11772InvestigationalPilaralisib has been used in trials studying the treatment of Cancer, Lymphoma, Solid Tumors, Glioblastoma, and Breast Cancer, among others. … Pilaralisib is an orally available small molecule that selectively inhibits the activity of phosphoinositide-3 kinase (PI3K).
Rostaporfin
go.drugbank.com/drugs/DB06659InvestigationalSynonyms: Tin ethyl etiopurpurinCategories: Heterocyclic Compounds with 4 or More RingsNerofe
go.drugbank.com/drugs/DB14786InvestigationalNerofe is under investigation in clinical trial NCT03059615 (A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS).